Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of carboplatin and vinorelbine in malignant pleural mesothelioma
2005-002223-14Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Aug 2005
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine and carboplatin in pleural mesothelioma, sponsored by Rigshospitalet. Primary endpoint: response rate. Started Aug 2005; status: completed.
02
Drugs
vinorelbinecarboplatin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2005-002223-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002223-14.